Virax Biolabs Group Limited

Virax Biolabs Group Limited - PE Ratioverified

VRAX

Price:

$0.173

Market Cap:

$751.16K

Virax Biolabs Group Limited is a biotechnology firm that specializes in the sale, distribution, and promotion of diagnostic testing kits, medical technology, and personal protective equipment (PPE). Its offerings are designed to aid in the prophylaxis, identification, diagnosis, and management of risks associated with viral illnesses within the immunology sector. Under its ViraxClear brand, the company provides a range of diagnostic tools, including rapid antibody IgG/IgM assays, antigen tests, polymerase chain reaction (PCR) rapid tests, and neutralizing antibody assessments. Additionally, it supplies medical technology and PPE products, such as employee safety gear marketed under the Virax...[Read more]

Industry

Biotechnology

IPO Date

2022-07-21

Stock Exchange

NASDAQ

Ticker

VRAX

The PE Ratio as of June 2026 (TTM) for Virax Biolabs Group Limited (VRAX) is -0.14

According to Virax Biolabs Group Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.14. This represents a change of -58.13% compared to the average of -0.33 of the last 4 quarters.

Virax Biolabs Group Limited (VRAX) Historical PE Ratio (quarterly & annually)

How has VRAX PE Ratio performed in the past?

The mean historical PE Ratio of Virax Biolabs Group Limited over the last ten years is -116.61. The current -0.14 PE Ratio has changed -87.99% with respect to the historical average. Over the past ten years (40 quarters), VRAX's PE Ratio was at its highest in in the March 2024 quarter at -0.11. The PE Ratio was at its lowest in in the March 2020 quarter at -2923.97.

Quarterly (TTM)
Annual

Average

-116.61

Median

-61.25

Minimum

-317.99

Maximum

-0.22

Virax Biolabs Group Limited (VRAX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Virax Biolabs Group Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 165.97%

Maximum Annual PE Ratio = -0.22

Minimum Annual Increase = -98.88%

Minimum Annual PE Ratio = -317.99

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.58165.97%
2024-0.22-83.83%
2023-1.35-98.88%
2022-121.14-61.90%
2021-317.9923.06%

Virax Biolabs Group Limited (VRAX) Average PE Ratio

How has VRAX PE Ratio performed in the past?

The current PE Ratio of Virax Biolabs Group Limited (VRAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.72

5-year avg

-88.26

10-year avg

-116.61

Virax Biolabs Group Limited (VRAX) PE Ratio vs. Peers

How is VRAX’s PE Ratio compared to its peers?

Virax Biolabs Group Limited’s PE Ratio is less than Windtree Therapeutics, Inc. (-0.00), greater than NewcelX Ltd. (-0.61), less than Moolec Science S.A. (-0.03), greater than Dermata Therapeutics, Inc. (-0.22), less than GT Biopharma, Inc. (-0.08), greater than Avenue Therapeutics, Inc. (-0.61), less than NKGen Biotech, Inc. Common Stock (-0.12), less than Artelo Biosciences, Inc. (-0.07), greater than XORTX Therapeutics Inc. (-0.20), less than PMGC Holdings Inc. (-0.01),

Build a custom stock screener for Virax Biolabs Group Limited (VRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virax Biolabs Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Virax Biolabs Group Limited (VRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Virax Biolabs Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Virax Biolabs Group Limited's PE Ratio?

How is the PE Ratio calculated for Virax Biolabs Group Limited (VRAX)?

What is the highest PE Ratio for Virax Biolabs Group Limited (VRAX)?

What is the 3-year average PE Ratio for Virax Biolabs Group Limited (VRAX)?

What is the 5-year average PE Ratio for Virax Biolabs Group Limited (VRAX)?

How does the current PE Ratio for Virax Biolabs Group Limited (VRAX) compare to its historical average?